Narcissus and Daffodil

212 J. Bastida and F. Viladomat
Späth, E., Kondo, H. and Kuffner, F. (1936) Über die identität des tazettins (aus Narcissus
tazetta L.) mit der Base VIII aus Lycoris radiata Herb. Chemische Berichte, 69, 1086–1087.
Spenglers, I. and Trimiño, Z. (1989) Determinación de la presencia de lactamas en la planta
Zephyrantes tubispatha Herb., Amaryllidaceae. Revista Cubana de Farmacia, 23, 151–154.
Spohn, M., Brecht, V. and Frahm, A.W. (1994) Revised assignment of 13 C-NMR signals to
quaternary carbons of the Amaryllidaceae alkaloid licorine. Archiv der Pharmazie, 327,
123–124.
Storch, A., Schrattenholz, A., Cooper, J.C., Ghani, E.M.A., Gutbrod, O., Weber, K.H.,
Reinhardt, S., Lobron, C., Hermsen, B., Soskiç, V., Pereira, E.F.R., Albuquerque, E.X.,
Methfessel, C. and Maelicke, A. (1995) Physostigmine, galanthamine, and codeine act
as ‘noncompetitive nicotinic receptor agonists’ on clonal rat pheochromocytoma cells.
European Journal of Pharmacology Molecular Pharmacology Section, 290, 207–219.
Suau, R., Rico, R., García, A.I. and Gómez, A.I. (1990a) New Amaryllidaceae alkaloids from
Narcissus papyraceus Ker-Gawler. Heterocycles, 31, 517–522.
Suau, R., Gómez, A.I. and Rico, R. (1990b) Ismine and related alkaloids from Lapiedra
martinezii. Phytochemistry, 29, 1710–1712.
Suhadolnik, R.J., Fischer, A.G. and Zulalian, J. (1963) Biogenesis of the Amaryllidaceae
alkaloids. Part III. Phenylalanine and protocatechuicaldehyde as C 6 –C 1 precursors of
haemanthamine and lycorine. Biochemical and Biophysical Research Communications, 208–212.
Suzuki, N., Tani, S., Furusawa, S. and Furusawa, E. (1974) Terapeutic activity of Narcissus
alkaloids on Rauscher Leukemia: Antiviral effect in vitro and rational drug combination in
vivo. Proceedings of the Society for Experimental Biology and Medicine, 145, 771–777.
Svensson, A.L. and Nordberg, A. (1997) Interaction of tacrine, galanthamine, NXX-066
and E2020 with neuronal α4β2 nicotinic receptors expressed in fibroblast cells. In:
K. Iqbal, B. Winblad, T. Nishimura, M. Takeda and H.M. Wisniewski (eds.), Alzheimer’s
Disease: Biology, Diagnosis and Therapeutics. John Wiley & Sons Ltd., Oxford, pp. 751–776.
Sweeney, J.E., Höhmann, C.F., Moran, T.H. and Coyle, J.T. (1988) A long-acting cholinesterase
inhibitor reverses spatial memory deficits in mice. Pharmacology Biochemistry and
Behavior, 31, 141–147.
Sweeney, J.E., Puttfarcken, P.S. and Coyle, J.T. (1989) Galanthamine, an acetylcholinesterase
inhibitor: A time course of the effects on performance and neurochemical parameters
in mice. Pharmacology Biochemistry and Behavior, 34, 129–137.
Szewczyk, J., Wilson, J.W., Lewin, A.H. and Carroll, F.I. (1995) Facile synthesis of (+/–)-,
(+)-, and (–)-galanthamine. Journal of Heterocyclic Chemistry, 32, 195–199.
Tani, S., Kobayashi, N., Fujiwara, H., Shingu, T. and Kato, A. (1981) Isolation of O-methylmaritidine
from bulbs of Narcissus tazetta L. Chemical and Pharmaceutical Bulletin, 29, 3381–
3384.
Tanker, M., Çitoglu, G., Gumusel, B. and Sener, B. (1996) Alkaloids of Sternbergia clusiana
and their analgesic effects. International Journal of Pharmacognosy, 34, 194–197.
Thomsen, T. and Kewitz, H. (1990) Selective inhibition of human acetylcholinesterase by
galanthamine in vitro and in vivo. Life Sciences, 46, 1553–1558.
Thomsen, T., Bickel, U., Fischer, J.P. and Kewitz, H. (1990) Stereoselectivity of cholinesterase
inhibition by galanthamine and tolerance in humans. European Journal of Clinical
Pharmacology, 39, 603–605.
Tojo, E. (1991) (+)-Narcidine, a new alkaloid from Narcissus pseudonarcissus. Journal of Natural
Products, 54, 1387–1388.
Tomioka, K., Koga, K. and Yamada, S.I. (1977) Stereochemical studies. XLIX. A biogenetic-type
total synthesis of natural (+)-maritidine from L-tyrosine using highly specific
asymmetric cyclization. Chemical and Pharmaceutical Bulletin, 25, 2681–2688.
Trimiño, Z., Iglesias, C., Sánchez, M. and Spengler, I. (1987) Estudio fitoquímico de Crinum
americanum L. Parte I. Alcaloides mayoritarios en hojas. Revista Cubana de Química, 3,
57–61.